On June 11, Qingsong Health declined 8.83% in regular trading, trading at HK$13.77 per share, with trading volume of approximately HK$32.71 million.

On the news front, the company's June lock-up expiry period is approaching, fueling persistent market anxiety. On June 10, the company's subsidiary signed a health management service cooperation agreement with Yingda Life Insurance covering medical services, chronic disease management, and rehabilitation care, which briefly lifted the stock over 8%, but the rebound failed to hold.

The company's shareholding structure is highly concentrated among a small number of shareholders, with extremely low average daily trading volume. The company has previously warned that even minimal buying or selling could trigger significant price swings. Since its historical high in March, the stock has cumulatively lost over 85%. Under the dual constraints of imminent lock-up expiry selling pressure and insufficient liquidity, the stock continues to exhibit a weak trajectory.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)